PRTN3 and rheumatoid arthritis: RA patients with the A1ATD PiMZ phenotype have been found to exhibit van increased prevalence and higher titers of anticitrullinated peptide autoantibodies (ACPA), indicating a distinct subset with greater disease severity (92).